BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
Lorenzo Bertani 1
1 University of Pisa, Pisa, Italy
Conference
UEG Week 2022
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing